Structure Therapeutics (GPCR) Current Leases (2022 - 2026)

Structure Therapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Current Leases rose 5.58% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (up 5.58% YoY), while the FY2025 annual figure was $2.9 million, up 69.49% from the prior year.
• Current Leases was $2.6 million for Q1 2026 at Structure Therapeutics, down from $2.9 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.9 million in Q4 2025 to a low of $73000.0 in Q2 2023.
• Historically, Current Leases has averaged $1.6 million across 5 years, with a median of $1.7 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Current Leases surged 2131.51% in 2024, then rose 5.58% in 2026.
• A 5-year view of Current Leases shows it stood at $260000.0 in 2022, then jumped by 453.85% to $1.4 million in 2023, then increased by 17.92% to $1.7 million in 2024, then jumped by 69.49% to $2.9 million in 2025, then declined by 9.35% to $2.6 million in 2026.
• The last three Current Leases figures came in at $2.6 million (Q1 2026), $2.9 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.